Dietary Supplements for Weight Loss and Drug Interactions
Metadatos
Mostrar el registro completo del ítemAutor
Rivas García, Francisco; García Sierra, José Antonio; Valverde Merino, María Isabel; Zarzuelo Romero, María JoséEditorial
MDPI
Materia
food supplements drug interactions obesity
Fecha
2024-12-09Referencia bibliográfica
Rivas García, F. et. al. Pharmaceuticals 2024, 17, 1658. [https://doi.org/10.3390/ph17121658]
Resumen
Food supplements are used for a variety of purposes, one of which is weight reduction. As
excess weight is a long-term condition, some supplements are expected to be used for long periods
of time. The long-term use of these dietary supplements makes it highly likely that they will be
combined with medications, increasing the risk of food supplement–drug interactions, which are not
always known or disclosed, and can lead to serious health problems, as has been observed. This article
discusses some of the compounds used as food supplements for weight reduction (green tea extract,
Garcinia cambogia, chitosan, quercetin and resveratrol) and the interactions they may cause with some
drugs such as: dextromethorphan, buspirone, diclofenac, irinotecan, 5-fluorouracil, cytochrome P450
inducers and inhibitors, statins, orlistat, warfarina, acenocoumarol, fluoxetine, valproate, quetiapine,
carbamazepine. This information is expected to be useful for healthcare professionals to detect
and intervene on food supplement–drug interactions to ensure the optimization of therapy and
patient safety.